These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9559312)
1. Ranolazine: a novel metabolic modulator for the treatment of angina. McCormack JG; Stanley WC; Wolff AA Gen Pharmacol; 1998 May; 30(5):639-45. PubMed ID: 9559312 [TBL] [Abstract][Full Text] [Related]
2. Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders. Bhandari B; Subramanian L Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):35-9. PubMed ID: 18221101 [TBL] [Abstract][Full Text] [Related]
3. Ranolazine: a potential new treatment for chronic stable angina. Anderson JR; Khou S; Nawarskas JJ Heart Dis; 2001; 3(4):263-9. PubMed ID: 11975803 [TBL] [Abstract][Full Text] [Related]
4. Ranolazine. A metabolic modulator for the treatment of chronic stable angina. Anderson JR; Nawarskas JJ Cardiol Rev; 2005; 13(4):202-10. PubMed ID: 15949056 [TBL] [Abstract][Full Text] [Related]
5. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Rupp H; Zarain-Herzberg A; Maisch B Herz; 2002 Nov; 27(7):621-36. PubMed ID: 12439634 [TBL] [Abstract][Full Text] [Related]